Tozaro is a biotech company leveraging molecular modelling and machine learning (ML) to design and develop stable and cost-effective polymers that bind to gene therapy vectors specifically & selectively. The Smart Polymer™ platform utilises >500 chemical groups to develop specific binding compounds, compared to traditional technologies using proteins and peptides, which use ca. 20 amino acids. Tozaro is able to mine a huge new chemical space using cost-effective Smart Polymers™
- Health
- Bedfordshire, United Kingdom
- £6m
- tozaro.com
- Update Information
More venture news
- 30 Mar 2026

Lucida MedicalLucida Medical secures £8.7m in funding led by IW Capital to detect early prostate cancer in scans with AI
EquityHealth - 23 Mar 2026

JAAQJAAQ raises £13m Series A from VC investors for a clinically governed mental health engagement platform
Series AHealth - 20 Mar 2026

FlexzoFlexzo raises a £9m Series A led by Octopus Ventures for its healthcare workforce orchestration platform
Series AHealth
